Literature DB >> 12046022

Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.

Godela M Fick-Brosnahan1, Mark M Belz, Kim K McFann, Ann M Johnson, Robert W Schrier.   

Abstract

In autosomal dominant polycystic kidney disease (ADPKD), renal function remains normal for many years into adult life while cysts form and expand progressively, starting in childhood. The longitudinal relationships between renal volume growth, hypertension, and renal function loss have not been examined in detail. At the University of Colorado (Denver, CO), 229 adult subjects with ADPKD participated in a longitudinal study from 1985 to 2001. Sequential ultrasound examinations were performed at a mean interval of 7.8 +/- 3.1 years (range, 2.6 to 15.1 years). Renal volume was calculated using a standard formula for a modified ellipsoid. The Modified Diet in Renal Disease equation was used to calculate glomerular filtration rate (GFR). The mean annual increase in renal volume was 46 +/- 55 cm3, and mean annual decline in GFR was 2.4 +/- 2.8 mL/min/1.73 m2. Men had faster renal growth, more severe hypertension, and a faster decline in GFR than women of similar ages. Multiple linear regression showed a significant relationship between rate of change in GFR and renal volume growth rate, initial renal volume, proteinuria, and age at entry. Correlational analysis showed a significant correlation between GFR and renal volume over time (R = -0.53) and between follow-up renal volume and follow-up GFR (R = -0.50) for both men and women. We conclude that renal volume and rate of renal volume growth may be useful markers for disease progression in early stages of ADPKD when GFR is preserved. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12046022     DOI: 10.1053/ajkd.2002.33379

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  61 in total

1.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

Review 2.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

Review 3.  An approach to cystic kidney diseases: the clinician's view.

Authors:  Christine E Kurschat; Roman-Ulrich Müller; Mareike Franke; David Maintz; Bernhard Schermer; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

4.  Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Authors:  Alan S L Yu; Chengli Shen; Douglas P Landsittel; Jared J Grantham; Larry T Cook; Vicente E Torres; Arlene B Chapman; Kyongtae Ty Bae; Michal Mrug; Peter C Harris; Frederic F Rahbari-Oskoui; Tiange Shi; William M Bennett
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

5.  Two autosomal dominant polycystic kidney (ADPKD) cases with advanced renal dysfunction, effectively treated with tolvaptan.

Authors:  Hirayasu Kai; Yuki Shinozaki; Airi Nishikubo; Megumi Watanabe; Takashi Tawara; Mamiko Iwase; Ryouya Tsunoda; Noriaki Moriyama; Toshiaki Usui; Tetsuya Kawamura; Kei Nagai; Masahiro Hagiwara; Chie Saito; Naoki Morito; Joichi Usui; Kunihiro Yamagata
Journal:  CEN Case Rep       Date:  2015-11-17

6.  Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.

Authors:  Kevin F Erickson; Glenn M Chertow; Jeremy D Goldhaber-Fiebert
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

7.  Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

Authors:  Imed Helal; Kim McFann; Berenice Reed; Xiang-Dong Yan; Robert W Schrier; Godela M Fick-Brosnahan
Journal:  Nephrol Dial Transplant       Date:  2012-12-04       Impact factor: 5.992

8.  Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.

Authors:  Rhona Capisonda; Veronique Phan; Jeffrey Traubuci; Alan Daneman; J Williamson Balfe; Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2003-01-21       Impact factor: 3.714

9.  Novel methodology to evaluate renal cysts in polycystic kidney disease.

Authors:  Kyongtae T Bae; Hongliang Sun; June Goo Lee; Kyungsoo Bae; Jinhong Wang; Cheng Tao; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Michal Mrug; William M Bennett; Michael F Flessner; Doug P Landsittel
Journal:  Am J Nephrol       Date:  2014-02-22       Impact factor: 3.754

10.  Semiautomated Segmentation of Polycystic Kidneys in T2-Weighted MR Images.

Authors:  Timothy L Kline; Marie E Edwards; Panagiotis Korfiatis; Zeynettin Akkus; Vicente E Torres; Bradley J Erickson
Journal:  AJR Am J Roentgenol       Date:  2016-06-24       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.